Iranian Journal of Orthopedic Surgery

Survey of Platelet-Riched Plasma Injection with and without Calcium Gluconate in Treatment of Patients with Knee Osteoarthritis

Document Type : Original Article

Authors

mohamad sheibani 1
mahmoud karimi.mobarake 2
hamid karimifard 3

1 orthopedic department, Afzalipour School of Medicine. Kerman University of Medical Sciences, Kerman, Iran

2 orthopedic department . afzalipor medicin school , , Kerman University of Medical Sciences, Kerman, Iran

3 orthopedic department ,afzalipor medicine school. Kerman University of Medical Sciences, Kerman, Iran

https://doi.org/10.22034/ijos.2021.284046.1001
Abstract
Introduction: The most common cause of knee pain is knee osteoarthritis, many surgical and non-surgical treatments have been proposed but the preferred treatment remains unknown. One of the non-surgical treatments was PRP (plasma reach platate) injection in these patients. Various studies have shown the improvement of the effect of PRP injection with substances such as calcium gluconate, so the aim of this study was to evaluate the effectof PRP with and without calcium gluconate on the clinical results of intra-articular injection of this substance in patients with knee osteoarthritis.
Methods: This was a cohort study in which patients were divided into two groups: PRP injection and PRP injection with calcium gluconate. The results of the study were evaluated by KOOS questionnaire and pain by VAS. A significance level of 0.05 was considered.
Result: Generally, during the study, the pain level in patients after receiving both treatments significantly decreased during the six-month period, while the pain in the case group significantly decreased. (P Value <0.05).
Discussion: From the results of this study, it can be concluded that simultaneous injection of PRP and calcium gluconate can further improve the results of injection.

Keywords

Platelet-Rich Plasma
Knee
Osteoarthritis of knee
Calcium Gluconate
Conservative Treatment

Subjects

  1. Cherry DK, Woodwell DA, Rechtsteiner EA, et al. National Ambulatory Medical Care survey: 2005 summary. Adv Data from Vital Heal Stat. 2007;387:1–40.
  2. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26–35.
  3. Percope de Andrade MA, de Oliveira Campos TV, de Abreue- Silva M. Supplementary methods in the nonsurgical treatment of osteoarthritis. Arthroscopy. 2015;31:785–792.
  4. da Costa BR, Nuesch E, Kasteler R, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2014:CD003115.
  5. Hassan F, Trebinjac S, Murrell WD, et al. The effectiveness of prolotherapy in treating knee osteoarthritis in adults: a systematic review. Br Med Bull. 2017;122:91–108.
  6. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19:528e535.
  7. Burdakov D, Jensen LT, Alexopoulos H, et al. Tandem-pore K + channels mediate inhibition of orexin neurons by glucose. Neuron. 2006;50:711–722.
  8. Jensen KT, Rabago DP, Best TM, et al. Early inflammatory response of knee ligaments to prolotherapy in a rat model.J Orthop Res. 2008;26:816–823.
  9. Rahimzadeh P, Imani F, Faiz SHR, et al. Investigation the efficacy of intra-articular prolotherapy with erythropoietin and dextrose and intra-articular pulsed radiofrequency on pain level reduction and range of motion improvement in primary osteoarthritis of knee. J Res Med Sci. 2014;19:696–702.
  10. del Carmen Caamano M, Garcia-Padilla S, Angel Duarte- Vazquez M, et al. A double-blind, active-controlled clinical trial of sodium bicarbonate and calcium gluconate in the treatment of bilateral osteoarthritis of the knee. Clin Med Insights Arthritis Musculoskelet Disord. 2017;10:1–7.
  11. García-Padilla S, Duarte-Vazquez MA, Gonzalez-Romero KE, et al. Effectiveness of intra-articular injections of sodium bicarbonate and calcium gluconate in the treatment of osteoarthritis of the knee: a randomized double-blind clinical trial. BMC Musculoskelet Disord. 2015;16:114–123.
  12. Kang S-J, Kim J-W, Kim K-Y, et al. Protective effects of calcium gluconate on osteoarthritis induced by anterior cruciate ligament transection and partial medial meniscectomy in Sprague-Dawley rats. J Orthop Surg Res. 2014;9:14–21.
  13. Roh Y, Kim W, Park K, Oh J. Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone and Joint Research. 2016;5(2):37-45.
  14. Li M, Zhang C, Ai Z, Yuan T, Feng Y, Jia W. [Therapeutic effectiveness of intraknee- articular injection of platelet-rich plasma on knee articular cartilage degeneration]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Zhongguo Xiufu Chongjian Waike Zazhi Chin J Reparative Reconstr Surg. 2011 Oct;25(10): 1192e1196
  15. Cavallo C, Roffi A, Grigolo B, et al. Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. BioMed Res Int. 2016, 6591717.
  16. Duymus TM, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas FN. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports raumatol Arthrosc Off J ESSKA. 2017 Feb;25(2):485e492
  17. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with plateletrich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013 Feb;41(2):356e364.
  18. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double- spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10): 2082e2091.
  19. Braddom RL. Physical medicine and rehabilitation: Elsevier Health Sciences; 2010.
  20. Forough B ME, Ahadi T, Raissi G, Fateh H, Moraveji SA. Single injection of platelet-rich plasma in knee osteoarthritis: a pilot study. Razi Journal of Medical Sciences. 2015;22(133):27-34.
  21. Rezaei S, Afsharnejad T, Moosavi SV, Yousefzadeh S, Soltani R. Validation of the Persian version of pain self efficacy scale: A Psychometric chronic low back pain patients. The Quarterly J Fundamentals of Mental Health. 2012;13(4):328-45.
  22. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. Journal of Orthopaedic & Sports Physical Therapy. 1998;28(2):88-96.
  23. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis a prospective, double-blind, randomized trial. The American journal of sports medicine. 2013;41(2):356-64.
  24. Gobbi A, Karnatzikos G, Malchira S, Kumar A. Platelet Rich Plasma (PRP) in Osteoarthritis. Platelet-Rich Plasma: Springer; 2014. p. 231-6.
  25. Kalbkhani M, N Dehghani S, Najafpour A, Naji Hadadi S, Ghorbanzadeh N, Kalbkhani MH. THE EFFECT OF PRP IN REPAIR OF FEMORAL ARTICULAR CARTILAGE NOTCHES ON EXPERIMENTALLY INDUCED OSTEOARTHRITIS RABBIT. URMIA MEDICAL JOURNAL. 2015;26(3):215-26.
  26. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sports Traumatology, Arthroscopy. 2010;18(4):472-9
  27. L. Andriolo,B.DiMatteo, E. Kon, G. Filardo, G. Venieri, andM. Marcacci, “PRP augmentation forACL reconstruction,” BioMed Research International, vol. 2015, Article ID 371746, 15 pages,2015.
  28. Y. Zhu, M. Yuan, H. Y. Meng et al., “Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review,” Osteoarthritis and Cartilage, vol. 21, no. 11, pp. 1627–1637, 2013.
  29. T. E. Foster, B. L. Puskas, B. R. Mandelbaum, M. B. Gerhardt, and S. A. Rodeo, “Platelet-rich plasma: from basic science to clinical applications,” The American Journal of Sports Medicine, vol. 37, no. 11, pp. 2259–2272, 2009.
  30. A. S. Wasterlain, H. J. Braun, and J. L. Dragoo, “Contents and formulations of platelet-rich plasma,” Operative Techniques in Orthopaedics, vol. 22, no. 1, pp. 33–42, 2012.
  31. B. Di Matteo, G. Filardo, E. Kon, and M. Marcacci, “Plateletrich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review,” Musculoskeletal Surgery, vol. 99, no. 1, pp. 1–9, 2015.
  32. P. Torricelli, M. Fini, G. Filardo et al., “Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses,” International Orthopaedics, vol. 35, no. 10, pp. 1569–1576, 2011.
  33. D. Fufa, B. Shealy, M. Jacobson, S. Kevy, and M. M. Murray, “Activation of platelet-rich plasma using soluble type I collagen,” Journal of Oral andMaxillofacial Surgery, vol. 66,no. 4, pp. 684– 690, 2008.
  34. Roh Y, Kim W, Park K, Oh J. Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone and Joint Research. 2016;5(2):37-45.
  35. Silva RF, Carmona JU, Rezende CM. Comparison of the effect of calcium gluconate and batroxobin on the release of transforming growth factor beta 1 in canine platelet concentrates. BMC veterinary research. 2012;8(1):1.

 

 

 

Home

Submit Manuscript

Contact Us